Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
OtherClinical Investigations (Human)

Imaging of the glucagon receptor in subjects with type 2 diabetes

Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J Larsen, Jan-Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner and Michael Wagner
Journal of Nuclear Medicine October 2020, jnumed.118.213306; DOI: https://doi.org/10.2967/jnumed.118.213306
Olof Eriksson
1 Uppsala University, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olof Eriksson
Irina Velikyan
1 Uppsala University, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Torsten Haack
2 Sanofi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Bossart
2 Sanofi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iina Laitinen
2 Sanofi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip J Larsen
2 Sanofi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan-Erik Berglund
3 Clinical Trial Consultants AB;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gunnar Antoni
1 Uppsala University, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Johansson
4 Antaros Medical AB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Pierrou
4 Antaros Medical AB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim Tillner
2 Sanofi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Wagner
2 Sanofi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.118.213306
DOI 
https://doi.org/10.2967/jnumed.118.213306
PubMed 
33097629

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online October 23, 2020.

Copyright & Usage 
Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Olof Eriksson1,
  2. Irina Velikyan1,
  3. Torsten Haack2,
  4. Martin Bossart2,
  5. Iina Laitinen2,
  6. Philip J Larsen2,
  7. Jan-Erik Berglund3,
  8. Gunnar Antoni1,
  9. Lars Johansson4,
  10. Stefan Pierrou4,
  11. Joachim Tillner2 and
  12. Michael Wagner2
  1. 1 Uppsala University, Sweden;
  2. 2 Sanofi;
  3. 3 Clinical Trial Consultants AB;
  4. 4 Antaros Medical AB
  1. For correspondence or reprints contact: Olof Eriksson, Uppsala University, Dag Hammarskjölds Väg 14C, 3tr, Uppsala, N/A 75183, Sweden. E-mail: olof.eriksson@ilk.uu.se

Article usage

Article usage: October 2020 to March 2021

AbstractFullPdf
Oct 2020380044
Nov 2020251011
Dec 2020139011
Jan 202113509
Feb 2021140011
Mar 202116608
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (4)
Journal of Nuclear Medicine
Vol. 62, Issue 4
April 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Imaging of the glucagon receptor in subjects with type 2 diabetes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Imaging of the glucagon receptor in subjects with type 2 diabetes
Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J Larsen, Jan-Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner, Michael Wagner
Journal of Nuclear Medicine Oct 2020, jnumed.118.213306; DOI: 10.2967/jnumed.118.213306

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Imaging of the glucagon receptor in subjects with type 2 diabetes
Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J Larsen, Jan-Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner, Michael Wagner
Journal of Nuclear Medicine Oct 2020, jnumed.118.213306; DOI: 10.2967/jnumed.118.213306
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • 68Ga-DOTA-FAPI-04 PET/MR in the evaluation of gastric carcinomas: comparison with 18F-FDG PET/CT
  • Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted 18F-FluorThanatrace (18F-FTT) PET images of ovarian cancer
  • Direct comparison of the tau PET tracers [18F]flortaucipir and [18F]MK-6240 in human subjects
Show more Clinical Investigations (Human)

Clinical (Endocrine/Neuroendocrine)

  • Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
  • First-in-human study of novel SSTR antagonist 177Lu-DOTA-LM3 for peptide receptor radionuclide therapy in patients with metastatic neuroendocrine neoplasms: dosimetry, safety and efficacy
  • Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker
Show more Clinical (Endocrine/Neuroendocrine)

Similar Articles

Keywords

  • Endocrine
  • Hepatology
  • Molecular Imaging
  • PET
  • glucagon
  • metabolic disease
  • obesity
  • type 2 diabetes
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire